Featuring perspectives from Dr Mazyar Shadman and cases from Dr
Daniel Ermann, Dr Shazia Nakhoda and Dr Mahesh Swaminathan,
including the following topics:
Case: A man in his mid 40s with chronic lymphocytic leukemia
(CLL) receives acalabrutinib/venetoclax as part of the MAJIC trial
(0:00)
Case: A man in his early 70s with TP53-mutated CLL expresses
concern about side effects associated with zanubrutinib (8:22)
Case: A man in his late 70s with Stage IIIB chronic kidney
disease and CLL receives obinutuzumab (18:02)
Featuring the video recorded proceedings of events held in conjunction with important scientific symposia, live webcasts and closed meetings featuring the perspectives of renowned clinical investigators, these videos provide an overview of important advances in the management of a number of solid tumors and hematologic cancers.